BioSpace News Archive

Feb. 12, 2020 14:00 UTC Healthcare Technology Company Becomes Organization’s Provider of Enterprise Solutions for Pharmacy Benefits Administration BOSTON--( BUSINESS WIRE )-- RxSense ®, the healthcare technology company, today announced a partnership with the Health Plan Alliance , a nationwide network of health plans and systems, to join its group purchasing organization as the provider of enterprise solutions for pharmacy benefits administration. RxSense will offer the

Feb. 12, 2020 14:00 UTC LAGUNA HILLS, Calif.--( BUSINESS WIRE )-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has received the Certificates of Analysis and the records from both batches of its clinical trial product manufactured by Austrianova Singapore (Austrianova). As previously reported, both batc

Feb. 12, 2020 14:00 UTC Advancement Aimed at Bridging Gap between Automation and Autonomy CAMBRIDGE, Mass.--( BUSINESS WIRE )-- For the National Center for Advancing Translational Sciences ( NCATS ), it’s all about delivering new treatments and cures for diseases faster. “If you ask a patient when they want their cure, they’ll say yesterday,” said Sam Michael, NCATS chief information officer. “Generating a new therapeutic can take 10 to 15 years and billions of dollars

Feb. 12, 2020 14:00 UTC SALT LAKE CITY--( BUSINESS WIRE )-- PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the pricing of an underwritten public offering of approximately 10,638,298 shares of its common stock and warrants to purchase up to 10,638,298 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase one share of common stoc

Glen Rock, N.J., Feb. 12, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), a leader in the development of medicines for respiratory disorders and central nervous system (“CNS”) indications, with a focus on obstructive sleep apnea, attention deficit hyperactivity disorder (“ADHD”), spinal cord injury and other neurological conditions, today provides a progress and status report to its stockholders, stakeholders, strategic partners as well as other interested parties. D

Dr. Laurence Klotz M.D., FRCSC, CM, the Chief Medical Officer of miR Scientific LLC, will present the results of the recently completed Case-Control validation study of 1,436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of 600 patients

Carnival Corporation & plc is closely monitoring the evolving situation with respect to Coronavirus. The safety of guests and employees, compliance and protecting the environment are top priorities for the company.

Feb. 12, 2020 14:00 UTC ACADIA to Host Conference Call and Webcast on Wednesday, February 26, 2020, at 5:00 p.m. Eastern Time SAN DIEGO--( BUSINESS WIRE )-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2019 financial results on Wednesday, February 26, 2020, after the close of the U.S. financial markets. ACADIA’s management team will also host a conference call and webcast on February 26, 2020, at 5:00 p.m. East

Orthopaedic & Neurosurgery Specialists (ONS), one of the nation’s leading providers of orthopaedic and neurosurgery services, announced today that Timothy F. Corvino, M.D., has been named Chief Executive Officer of the organization, effective March 1.

Feb. 12, 2020 14:05 UTC Novel MRI system is a breakthrough in patient accessibility and cost GUILFORD, Conn.--( BUSINESS WIRE )-- Hyperfine Research, Inc. announced today that it has received US Food & Drug Administration 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system, clearing the way for device shipments this summer. The Hyperfine system is 20X lower cost, 35X lower power consumption, and 10X lower weight than today’s fixed conv